Hyperhomocysteinaemia, a risk factor for atherosclerosis: Causes and effects;Atheroskleroserisikofaktor hyperhomocyst(e)inamie: Ursachen und konsequenzen

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 38, 1999, Pages 1107-1113

  Weiss, Norbert ^a,c   Pietrzik, K ^b   Keller, C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; FOLIC ACID; LIPOPROTEIN; METHIONINE; PYRIDOXINE;

AMINO ACID METABOLISM; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; GENETIC RISK; HUMAN; HYPERHOMOCYSTEINEMIA; REVIEW; RISK FACTOR; AGE; ARTERIOSCLEROSIS; BLOOD; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; LIPID METABOLISM; MALE; META ANALYSIS; METABOLISM; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

AGE FACTORS; ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LIPID METABOLISM; LIPOPROTEINS; MALE; META-ANALYSIS; METHIONINE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; PYRIDOXINE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEX FACTORS;

EID: 0033600668     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024499     Document Type: Review

References (43)

1. Arnadottir, M., B. Hultberg, P. Nilsson Ehle, H. Thysell: The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand. J. Clin. Lab. Invest. 56 (1996), 41-46.
2. Arnesen, E., H. Refsum, K. H. Boonaa, P. M. Ueland, O. H. Forde, J. E. Nordrehaug: Serum total homocysteine and coronary heart disease. Int. J. Epidemiol. 24 (1995), 704-709.
3. Boushey, C. J., S. A. A. Beresford, G. S. Omenn, A. G. Motulsky: A quantitative assessement of plasma homocysteine as a risk factor for vascular disease. J. Amer Med. Ass. 274 (1995), 1049-1057.
4. Celermajer, D. S., K. Sorensen, M. Ryalls, J. Robinson, O. Thomas, J. V. Leonard, J. E. Deanfield: Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J. Amer. Coll. Cardiol. 22 (1993), 854-858.
5. Den Heijer, M., I. A. Brouwer, G. M. Bos, H. J. Blom, N. M. van der Put, A. P. Spaans, F. R. Rosendaal, C. M. Thomas, H. L. Haak, P. W. Wijermans, W. B. Gerrits: Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler. Thromb. Vasc. Biol. 18 (1998), 356-361.
6. Den Heijer, M., T. Kostor, H. J. Blom, G. M. J. Bos, E. Briet, P. H. Reitsma, J. P. Vendenbroucke, F. R. Rosendaal: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New Engl. J. Med. 334 (1996), 759-762.
7. Franken, D. C., G. H. J. Boers, H. J. Blom, F. J. M. Trijbels, P. W. C. Kloppenborg: Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler. Thromb. 14 (1994), 465-470.
8. Graham, I. M., L. E. Daly, H. M. Refsum, K. Robinson, L. E. Brattstrom, P. M. Ueland, R. J. Palma Reis, G. H. Boers, R. G. Sheahan, B. Israelsson, C. S. Uiterwaal, R. Meleady, D. McMaster, P. Verhoef, J. Witteman, P. Rubba, H. Bellet, J. C. Wautrecht, H. W. de Valk, A. C. Sales Luis, F. M. Parrot Rouland, K. S. Tan, I. Higgins, D. Garcon, G. Andria: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J. Amer. Med. Ass. 277 (1997), 1775-1781.
9. Harker, L. A., R. Ross, S. J. Slichter, C. R. Scott: Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 58 (1976), 731-741.
10. Harker, L. A., S. J. Slichter, C. R. Scott, R. Ross: Homocysteinemia: vascular injury and arterial thrombosis. New Engl. J. Med. 291 (1974), 537-543.
11. Hoogeveen, E. K., P. J. Kostense, P. J. Beks, A. J. C. Mackaay, C. Jakobs, L. M. Bouter, R. J. Heine, C. D. A. Stehouwer: Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus. A population-based study. Arterioscler. Thromb. Vasc. Biol. 18 (1998), 133-138.
12. James, T. N.: The spectrum of diseases of small coronary arteries and their physiologic consequences. J. Amer. Coll. Cardiol. 15 (1990), 763-774.
13. Jones, B. G., F. A. Rose, N. Tudball: Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 105 (1994), 165-170.
14. Kang, S.-S., J. Zhou, P. W. K. Wong, J. Kowalisyn, G. Strokosch: Intermediate homocysteinemia: a thermolabile variant of methylentetra-hydrofolate reductase. Amer. J. Hum. Genet. 43 (1988), 414-421.
15. Lentz, S. R., C. G. Sobey, D. J. Piegors, M. Y. Bhopatkar, F. M. Faraci, M. R. Malinow, D. D. Heistad: Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J. Clin. Invest. 98 (1996), 24-29.
16. Malinow, M. R., A. G. Bostom, R. M. Kraus: Homocyst(e)ine, diet, and cardiovascular diseases. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99 (1999), 178-182.
17. Malinow, M. R., P. B. Duell, D. L. Hess, P. H. Anderson, W. D. Kruger, B. E. Phillipson, R. A. Gluckman, P. C. Block, B. M. Upson: Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. New Engl. J. Med. 338 (1998), 1009-1015.
18. Mayer, E. L., D. W. Jacobsen, K. Robinson: Homocysteine and coronary atherosclerosis. J. Amer. Coll. Cardiol. 27 (1996), 517-527.
19. McCully, K. S. The Homocysteine Revolution. Medicine for the New Millennium (Keats: New Canaan 1997).
20. McCully, K. S.: Homocysteine and vascular disease. Nature Med. 2 (1996), 386-389.
21. McCully, K. S.: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Amer. J. Pathol. 56 (1969), 111-128.
22. Mudd, S. H., H. L. Levy, F. Skovby. Disorders of Transsulfuration. In: Scriver, C.R., A. L. Beaudet, W. S. Sly, D. Valle (Ed): The metabolic and molecular bases of inherited diseases. (McGraw-Hill: New York 1995), 1279-1327.
23. Naurath, H. J., E. Joosten, R. Riezler, S. P. Stabler, R. H. Allen, J. Lindenbaum: Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346 (1995), 85-89.
24. Nordström, M., T. Kjellström: Age dependency of cystathionine betasynthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease. Atherosclerosis 94 (1992), 213-221.
25. Ridker, P. M., C. H. Hennekens, J. Selhub, J. P. Miletich, M. R. Malinow, M. J. Stampfer: Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 95 (1997), 1777-1782.
26. Rimm, E. B., W. C. Willett, F. B. Hu, L. Sampson, G. A. Colditz, J. E. Manson, C. Hennekens, M. J. Stampfer: Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J. Amer. med. Ass. 279 (1998), 359-364.
27. Robinson, K., K. Arheart, H. Refsum, L. Brattström, G. Boers, P. Ueland, P. Rubba, R. Palma-Reis, R. Meleady, L. Daly, J. Witteman, I. Graham, for the European COMAC Group: Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 97 (1998), 437-443.
28. Selhub, J., P. F. Jacques, A. G. Bostom, D. A. RB, P. W. Wilson, A. J. Belanger, O. L. DH, P. A. Wolf, E. J. Schaefer, J. H. Rosenberg: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New Engl. J. Med. 332 (1995), 286-291.
29. Selhub, J., P. F. Jacques, P. W. F. Wilson, D. Rush, I. H. Rosenberg: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Amer. Med. Ass. 124 (1993), 1927-1933.
30. Selhub, J., P. Jacques, A. G. Boston, R. B. D'Agostino, P. W. F. Wilson, A. J. Belanger, D. H. O'Leary, P. A. Wolf, D. Rush, E. J. Schaefer, I. H. Rosenberg: Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. J. Nutr. 126 (1996), 1258S-1265S.
31. Smolin, L. A., T. D. Crenshaw, D. Kurtyez, N. J. Benevenga: Homocyst(e)ine accumulation in pigs fed diets deficient in vitamin B-6: relationship to atherosclerosis. J. Nutr. 113 (1983), 2022-2033.
32. Stabler, S. P., P. D. Marcell, E. R. Podell, R. H. Alien, D. G. Savage, J. Lindenbaum: Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass Spectrometry. J. Clin. Invest. 81 (1988), 466-474.
33. Stampfer, M. J., M. R. Malinow, W. C. Willett, L. M. Newcomer, B. Upson, D. Ullmann, P. V. Tishler, C. H. Henneckens: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in U.S. physicians. J. Amer. Med. Ass. 268 (1992), 877-881.
34. Tawakol, A., T. Omland, M. Gerhard, J. T. Wu, M. A. Creager: Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95 (1997), 1119-1121.
35. Tsai, J. C., M. A. Perrella, M. Yoshizumi, C. M. Hsieh, E. Haber, R. Schlegel, M. E. Lee: Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. USA 91 (1994), 6369-6373.
36. Ubbink, J. B., W. J. H. Vermaak, A. v.d.Merwe, P. J. Becker, R. Delport, H. Potgieter: Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124 (1994), 1927-1933.
37. Ubbink, J. B., W. J. K. Vermaak, A. van der Merwe, P. J. Becker: Vitamin B-12, vitamin B-6 and folate nutritional status in men with hyperhomocysteinemia. Amer. J. Clin. Nutr. 57 (1993), 47-53.
38. Ueland, P. M., H. Refsum: Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy. J. Lab. Clin. Med. 114 (1989), 473-501.
39. Upchurch, G. R., G. N. Welch, A. J. Fabian, J. E. Freedman, J. L. Johnson, J. F. Keaney, J. Loscalzo: Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272 (1997), 17012-17017.
40. Verhoef, P., F. J. Kok, D. A. Kruyssen, E. G. Schouten, J. C. Witteman, D. E. Grobbee, P. M. Ueland, H. Refsum: Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17 (1997), 989-995.
41. Welch, G. N., G. R. Upchurch, R. S. Farivar, A. Pigazzi, K. Vu, P. Brecher, J. F. Keaney, J. Loscalzo: Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activiation of Nos2. Proc. Assoc. Am. Physicians 110 (1998), 22-31.
42. Welch, G. N., J. Loscalzo: Homocysteine and atherothrombosis. New Engl. J. Med. 338 (1998), 1042-1050.
43. Wu, L. L., J. Wu, S. C. Hunt, B. C. James, G. M. Vincent, R. R. Williams, P. N. Hopkins: Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin. Chem. 40 (1994), 552-561.